Clinical Trial Update: Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated whether weaning immunosuppression after liver transplantation reduces hepatitis C–related liver damage; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Hepatitis C Virus Infection, Liver Transplantation | Phase 2 | Status: COMPLETED